Ning, K.; Li, Z.; Liu, H.; Tian, X.; Wang, J.; Wu, Y.; Xiong, L.; Zou, X.; Peng, Y.; Zhou, Z.;
et al. Perirenal Fat Thickness Significantly Associated with Prognosis of Metastatic Renal Cell Cancer Patients Receiving Anti-VEGF Therapy. Nutrients 2022, 14, 3388.
https://doi.org/10.3390/nu14163388
AMA Style
Ning K, Li Z, Liu H, Tian X, Wang J, Wu Y, Xiong L, Zou X, Peng Y, Zhou Z,
et al. Perirenal Fat Thickness Significantly Associated with Prognosis of Metastatic Renal Cell Cancer Patients Receiving Anti-VEGF Therapy. Nutrients. 2022; 14(16):3388.
https://doi.org/10.3390/nu14163388
Chicago/Turabian Style
Ning, Kang, Zhen Li, Huiming Liu, Xi Tian, Jun Wang, Yi Wu, Longbin Xiong, Xiangpeng Zou, Yulu Peng, Zhaohui Zhou,
and et al. 2022. "Perirenal Fat Thickness Significantly Associated with Prognosis of Metastatic Renal Cell Cancer Patients Receiving Anti-VEGF Therapy" Nutrients 14, no. 16: 3388.
https://doi.org/10.3390/nu14163388
APA Style
Ning, K., Li, Z., Liu, H., Tian, X., Wang, J., Wu, Y., Xiong, L., Zou, X., Peng, Y., Zhou, Z., Zhou, F., Yu, C., Luo, J., Zhang, H., Dong, P., & Zhang, Z.
(2022). Perirenal Fat Thickness Significantly Associated with Prognosis of Metastatic Renal Cell Cancer Patients Receiving Anti-VEGF Therapy. Nutrients, 14(16), 3388.
https://doi.org/10.3390/nu14163388